Netherlands vs Nigeria: Access to anti-retroviral drugs, female
Netherlands
89.0%
in 2023
Nigeria
89.0%
in 2024
Netherlands rank
35th
Nigeria rank
35th
Access to anti-retroviral drugs, female over time
- Netherlands
- Nigeria
How they compare
Netherlands currently reports 89.0% against 89.0% in Nigeria, a difference of 0.0%.
Across all 24 years both countries report, Netherlands has been ahead every year.
Netherlands ranks 35th and Nigeria ranks 35th of 141 countries.
Netherlands has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Netherlands | Nigeria | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 62.9% | 5.0% | 57.9% | Netherlands |
| 2010s | 77.7% | 43.4% | 34.3% | Netherlands |
| 2020s | 86.8% | 76.0% | 10.8% | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Netherlands or Nigeria?
- Netherlands, at 89.0% against 89.0% in Nigeria as of 2023.
- What is the difference in access to anti-retroviral drugs, female between Netherlands and Nigeria?
- 0.0%, with Netherlands ahead.
- How many years of comparable data are there for Netherlands and Nigeria?
- 24 years are reported by both, from 2000 to 2023.
- How do Netherlands and Nigeria rank globally for access to anti-retroviral drugs, female?
- Netherlands ranks 35th and Nigeria ranks 35th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.